Simultaneously affecting the expression levels of E-cadherin and N-cadherin, as well as the EMT process, SHMT2 deficiency induces cell apoptosis, ultimately affecting the progression of BLCA. The gene discussed is SHMT2; the disease is bladder transitional cell carcinoma.